Clinical observation on the application of nabuphine, dexmedetomidine and dizocine in cesarean section under combined spinal epidural anesthesia

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031377

Enrollment

Unknown

Registered

2020-03-29

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cesarean section

Interventions

Group 1:intravenous injection saline

Group 2:intravenous injection dizocine

Group 3:intravenous injection dexmedetomidine

Group 4:intravenous injection nalbuphine

Group 5:Intrathecal administration of nabulphine

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA I-II, cesarean section patients, aged 20-40 years, can cooperate with the completion of the experiment.

Exclusion criteria

Exclusion criteria: 1) contraindication of intravertebral anesthesia; 2) thyroid disease; 3) allergic to local anesthetics or opioids; 4) abnormal heart, liver, lung and kidney function; 5) multiple pregnancies, placenta praevia, placental abruption, women with history of abdominal surgery; 6) gestational age < 36 weeks.

Design outcomes

Primary

Measure	Time frame
visceral pain;shiver;nausea and vomiting;	—

Secondary

Measure	Time frame
Ramsay sedation score;	—

Countries

China

Contacts

Public ContactLi Yuanhai

The First Affiliated Hospital of Anhui Medical University

liyuanhai-1@163.com+86 13505697561

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026